Transthyretin amyloid cardiomyopathy is a rare, progressive heart disease caused by accumulation of abnormal transthyretin protein deposits in the heart. The deposition of these protein depo… Read More
The US Food and Drug Administration (FDA) has given the nod to AstraZeneca’s Voydeya (danicopan) as an add-on therapy to the company’s standard-of-care C5 inhibitors Ultomiris (r… Read More
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare but fatal form of heart disease caused by amyloid deposits made of abnormal transthyretin protein building up in the heart muscle. Le… Read More
Market Dynamics: The global amyloidosis market is poised to experience a robust revenue Compound Annual Growth Rate (CAGR) throughout the forecast period. Factors driving market revenue grow… Read More
New York, United States, 2024-Feb-09 — /EPR Network/ —” “According to the research report, the global transthyretin amyloidosis treatment market was valued at USD 4.7… Read More
Antisense and RNAi therapeutics hold promise for inhibiting the expression of disease-causing genes through modulating or “silencing” messenger RNA (mRNA). Key products involve a… Read More
New York, United States, 2024-Jan-09 — /EPR Network/ — Polaris Market Research has recently released research report titled Transthyretin Amyloidosis Treatment Market 2024: By Ty… Read More
New York, United States, 2023-Dec-21 — /EPR Network/ — “According to the research report, the global transthyretin amyloidosis treatment market was valued at USD 4.72 [read… Read More
New York, United States, 2023-Dec-07 — /EPR Network/ — “According to the research report, the global transthyretin amyloidosis treatment market was valued at USD 4.72 [read… Read More
New York, United States, 2023-Nov-23 — /EPR Network/ — “According to the research report, the global transthyretin amyloidosis treatment market was valued at USD 4.72 [read… Read More
New York, United States, 2023-Nov-16 — /EPR Network/ — “According to the research report, the global transthyretin amyloidosis treatment market was valued at USD 4.72 [read… Read More
New York, United States, 2023-Nov-10 — /EPR Network/ — “According to the research report, the global transthyretin amyloidosis treatment market was valued at USD 4.72 [read… Read More
As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new te… Read More
New York, United States, 2023-Oct-17 — /EPR Network/ —Transthyretin amyloidosis is a protein disorder where clumps of irregular protein known as fibrils build up in [read full pr… Read More
Olezarsen Phase 3 data showed significant triglyceride lowering, substantial reductions in acute pancreatitis attacks and favorable safety and tolerability in patients with FCS; on track f… Read More
Gamertsfelder is a clinical and policy researcher. Osipenko leads a non-profit dedicated to improving the quality and integrity of clinical research… Read More
Clinical-stage genome editing company Intellia Therapeutics has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to start… Read More
The US Cancer Vaccine Market is predicted to grow at a CAGR of ~17% which would result in making it an approximately USD 7 Bn industry by 2028 as per the findings of Ken Research.
STORY O… Read More
Pfizer Inc. (NYSE: PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas… Read More
The ‘Global Pegfilgrastim Biosimilars Market Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global pegfilgrastim biosimilars mark… Read More
Delveinsight Business Research LLP
As per DelveInsight’s assessment, globally, about 75+ key pharma and biotech companies are working on 80+ pipeline drugs in the Wet Age-Related Mac… Read More
The ‘Global Cyclophosphamide Drug Market Report and Forecast 2023-2031’ by Expert Market Research provides a comprehensive outlook on the global cyclophosphamide drug market… Read More
Existing research shows that nucleic acids can be used for the treatment of neurological diseases, cardiovascular diseases, and cancer, as well as for the prevention of chronic and infectiou… Read More
The ‘North America Vapour Barrier Market Size, Share, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the North America vapour barrier mark… Read More
Multiple Myeloma
92% was the overall response rate produced by NXC-201 in relapsed/refractory multiple myeloma patients treated at the therapeutic dose of 800 million CAR+T cells in its on… Read More
factor xi deficiency :: Article CreatorFactor X Deficiency Factor X deficiency is a condition caused by not enough of the protein factor X in your blood. This coa… Read More
Vutrisiran Market
DelveInsight’s “Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Vutrisiran, historic… Read More
Amiclear – The Blood Sugar Formula That Promises To Keep You Healthy
“Amiclear is a blood sugar formula that promises to keep you healthy. The makers of Amiclear&n… Read More
IONS (Ionis Pharmaceuticals, Inc.) SVB Leerink boosted their earnings-per-share expectations for Ionis Pharmaceuticals for the fourth quarter of 2022 in a research note published on Wednesda… Read More
On Thursday, November 3, before the opening of the stock market, Intellia Therapeutics (NASDAQ: NTLA) will announce the monetary outcomes of its most recent quarterly report. The majority op… Read More
Investors are facing a storm of headwinds right now – a genuine bear market, stubbornly high inflation, rising interest rates, and increased fears of a recession in the near-term… Read More
With the continuous development of molecular biology technology, the relationship between gene mutations and diseases has gained more and more in-depth understanding. Nucleic acids have attr… Read More
The Antisense and RNAi Therapeutics Market is classified into technology, application, and route of administration. In terms of technology, the global antisense and RNAi therapeutics market… Read More
In the latest issue of the JMC journal, a review article, entitled “A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions”, was published, which analyzed and s… Read More
Biotech stocks headed higher in the week finished Dec. 5 as more extensive market hopefulness infested into the area. The area likewise kept on getting support from immunization related posi… Read More
Boston, Massachusetts--(Newsfile Corp. - April 10, 2020) - Thornton Law Firm LLP, a law firm that represents shareholders in recovery actions, is investigating potential breach of fiduciary… Read More
The Burden of Alzheimer’s Disease
Almost everybody in the US has been affected by Alzheimer’s Disease. The Centers for Disease Control and Prevention (CDC) reports Alzheimer&rsqu… Read More